Skip to main content
logo
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
673.82
-2.72 (-0.40%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Thermo Fisher Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Revenue
47,35146,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,211
Revenue Growth
8.27%7.23%5.36%3.91%3.22%2.04%0.95%0.05%-2.42%-2.71%-3.00%-4.58%-1.69%1.64%6.53%14.55%13.08%11.95%14.57%21.70%
Gross Profit
19,49718,99218,50018,30218,10117,84817,77517,74917,32017,31017,23417,10017,38617,35817,68818,97119,61119,96019,88519,638
Operating Income
9,0928,7978,4878,3588,1867,9507,8427,7277,4567,5247,4777,3227,5217,2727,4548,5609,2829,87410,11510,372
Net Income
7,0726,9676,8486,7046,5706,5846,5146,3356,1356,2206,0345,9955,9415,7216,0246,9507,0327,4397,6037,725
Earnings Per Share
18.9718.5818.1917.7417.3217.3017.0616.5315.9516.1315.5915.4515.2614.6415.3417.6317.7918.7919.1919.46
EPS Growth
9.54%7.45%6.67%7.32%8.54%7.24%9.37%6.99%4.56%10.18%1.64%-12.37%-14.23%-22.09%-20.03%-9.40%-17.43%-12.99%-3.46%21.93%

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Life Sciences Solutions
11,11610,98510,66910,37410,0329,8319,6879,6319,4969,5429,6509,97710,55411,08311,91213,53114,63515,39415,65915,631
Analytical Instruments
7,7807,6717,5527,5547,5257,4407,4947,4637,3147,2607,2277,2637,1046,9716,8296,6246,4716,3266,2006,069
Specialty Diagnostics
4,6654,7414,6704,6764,6134,5684,5514,5124,4604,4144,4064,4054,4154,3974,3894,7635,0955,3925,5265,659
Laboratory Products and Biopharma Services
25,97125,07824,38023,98423,54123,31123,07423,15722,94022,92823,00123,04123,26923,12622,83222,51120,75918,66116,70714,862
Revenue (Total)
47,35146,33645,19744,55643,73643,21242,89842,87942,37042,34642,49242,85743,42143,52443,80744,91544,16742,82041,12339,211

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Cash & Investments
6,0614,0643,25610,1053,5466,3905,9475,5706,6458,8237,2508,0806,1513,1333,4828,5242,9191,8882,7524,477
Total Debt
41,37042,54943,16140,85535,68035,22934,25932,77535,51335,42735,66436,71135,43634,02335,33636,15829,16030,26033,25536,339
Net Cash (Debt)
-35,309-38,485-39,905-30,750-32,134-28,839-28,312-27,205-28,868-26,604-28,414-28,631-29,285-30,890-31,854-27,634-26,241-28,372-30,503-31,862
Net Cash Growth
--------------------
Net Cash Per Share
-94.54-102.63-105.99-81.35-84.73-75.79-74.16-71.03-75.13-69.01-73.42-73.79-75.33-79.00-81.21-70.14-66.35-71.74-76.93-80.26

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Operating Cash Flow
9,3249,0138,2877,8187,6517,5788,1398,6679,1009,3488,9288,4068,1707,6937,6819,1548,1248,8379,5369,312
Capital Expenditures
-1,728-1,695-1,539-1,525-1,540-1,408-1,415-1,400-1,325-1,385-1,368-1,479-1,624-1,839-2,061-2,243-2,524-2,501-2,535-2,523
Free Cash Flow
7,5967,3186,7486,2936,1116,1706,7247,2677,7757,9637,5606,9276,5465,8545,6206,9115,6006,3367,0016,789
Free Cash Flow Growth
24.30%18.61%0.36%-13.40%-21.40%-22.52%-11.06%4.91%18.77%36.03%34.52%0.23%16.89%-7.61%-19.73%1.80%-29.26%-22.09%-13.16%-0.38%

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Gross Margin
41.17%40.99%40.93%41.08%41.39%41.30%41.44%41.39%40.88%40.88%40.56%39.90%40.04%39.88%40.38%42.24%44.40%46.61%48.35%50.08%
Operating Margin
19.20%18.98%18.78%18.76%18.72%18.40%18.28%18.02%17.60%17.77%17.60%17.09%17.32%16.71%17.02%19.06%21.02%23.06%24.60%26.45%
Pretax Margin
16.55%16.37%16.35%16.31%16.28%16.25%16.29%16.31%15.95%16.01%15.33%14.56%14.39%13.85%14.79%17.06%17.61%19.67%20.93%22.54%
Profit Margin
14.94%15.04%15.15%15.05%15.02%15.24%15.19%14.77%14.48%14.69%14.20%13.99%13.68%13.14%13.75%15.47%15.92%17.37%18.49%19.70%
FCF Margin
16.04%15.79%14.93%14.12%13.97%14.28%15.67%16.95%18.35%18.80%17.79%16.16%15.08%13.45%12.83%15.39%12.68%14.80%17.03%17.31%

Dividends
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
Dividend Per Share
0.4301.8001.7601.7201.6801.6401.6001.5601.5201.4801.4401.4001.3501.3001.2501.2001.1601.1201.0801.040
Dividend Per Share Growth
-74.41%9.76%10.00%10.26%10.53%10.81%11.11%11.43%12.59%13.85%15.20%16.67%16.38%16.07%15.74%15.38%16.00%16.67%17.39%18.18%
Dividend Yield
0.06%0.35%0.37%0.30%0.36%0.40%0.32%0.30%0.25%0.27%0.25%0.26%0.26%0.25%0.22%0.22%0.23%0.20%0.18%0.16%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21
PE Ratio
35.2927.3725.6832.4726.6823.4128.9731.4138.2633.9436.7334.2133.3335.1836.8831.2228.2628.8530.4834.04
Forward PE
25.6920.2219.2224.0519.8117.9221.4122.8727.3124.8226.9324.6521.3921.2524.2725.0022.6625.0226.2932.55
P/FCF Ratio
32.8626.0526.0634.6028.6924.9828.0627.3830.1926.5129.3229.6130.2534.3839.5331.4035.4833.8733.1038.73
PS Ratio
5.274.123.894.894.013.574.404.645.544.995.224.794.564.625.074.834.505.015.646.71